Measurable benefits for society and the environment.
User research indicates 78% reduction in allergic rhinitis symptoms among users. Significantly decreased medication dependency and improved quality of life for allergy sufferers.
By redefining respiratory protection as a comfortable, daily practice, 76% of users report making the nose mask a consistent part of their routine during allergy season.This demonstrates a significant move away from reactive symptom management towards proactive prevention.
Customizable patterns and popular IP collaborations reduce the stigma of protection, empowering users to express individuality while staying safe.
Addresses the global challenge of respiratory allergies affecting 30%+ of the population. Reduces healthcare burden by preventing allergy-related complications and hospital visits.